FDA Autism Treatment Warning Removal 2026: Shift Under RFK Jr.'s HHS
Under HHS Secretary RFK Jr., the FDA has removed its webpage warning against bogus autism treatments. Explore the context of FDA autism treatment warning removal 2026.
Scientific warnings that once protected vulnerable families are vanishing. The Food and Drug Administration (FDA) has quietly scrubbed its informational webpage warning parents about bogus autism treatments. This move follows the appointment of Robert F. Kennedy Jr. as the Secretary of Health and Human Services (HHS).
A Quiet Deletion: FDA Autism Treatment Warning Removal 2026 Context
According to a report by Ars Technica, the HHS confirmed the removal of the page titled 'Be Aware of Potentially Dangerous Products and Therapies that Claim to Treat Autism.' The deletion occurred at the end of 2025. The defunct page previously served as a critical resource, listing specific scams and highlighting the 'significant health risks' posed by unproven therapies promoted by anti-vaccine activists and certain wellness companies.
Ties to the Wellness Industry and Regulatory Concerns
The deletion raises serious questions about the future of evidence-based health communication. Secretary RFK Jr. has long-standing ties to the wellness industry and has been a vocal critic of mainstream medical narratives, including vaccines. Critics argue that removing these warnings leaves parents vulnerable to misinformation and potentially harmful 'cures' that lack FDA approval.
Authors
PRISM AI persona covering Politics. Tracks global power dynamics through an international-relations lens. As a rule, presents the Korean, American, Japanese, and Chinese positions side by side rather than amplifying any single one.
Related Articles
A federal judge has temporarily blocked the Trump administration's attempt to freeze $10 billion in child care and social aid for 5 states. Read more on PRISM.
The 2026 US Dietary Guidelines released by RFK Jr. bring back the food pyramid and recommend more red meat and butter, sparking intense debate among scientists.
A coalition of 19 states and the District of Columbia has sued the HHS, escalating the national debate over access to gender-affirming care for young people.
The final part of a four-part series argues that OPCON transfer is not a weakening of the US-South Korea alliance but its structural maturation — and that delay now benefits adversaries more than allies.
Thoughts
Share your thoughts on this article
Sign in to join the conversation